Novo Nordisk | driving change to defeat serious chronic diseases
2 days ago · Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Novo Nordisk - Wikipedia
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark [3] with production facilities in nine countries and affiliates or offices in five countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting ...
Who we are - Novo Nordisk
We are a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes.
Locations - Novo Nordisk
Don't see your location on the list? We have offices in these locations. From here you can visit the local website of your country.
Novo Nordisk to build $1.2B rare disease drug factory in Denmark
Dec 16, 2024 · Novo Nordisk is laying out 8.5 billion Danish kroner (about $1.2 billion) to establish a brand-new manufacturing plant in Odense, Denmark, where the company eventually plans to hire on...
The single company propping up an entire economy - Financial …
Sep 17, 2023 · London | If you suffer from obesity, Danish pharmaceutical giant Novo Nordisk has two talk-of-the-town drugs, Ozempic and Wegovy, that might be able to help you slim down. But for Denmark as...
Velkommen til Novo Nordisk Danmark
Vi er en global lægemiddelvirksomhed, der blev grundlagt i 1923 med hovedkontor lige uden for København. Vores formål er at drive forandring for at bekæmpe diabetes og andre alvorlige kroniske sygdomme som svær overvægt og sjældne blodsygdomme og endokrine sygdomme.
Novo Nordisk's obesity-fighting drugs fatten Denmark's …
Nov 4, 2024 · Novo Nordisk's blockbuster drugs Ozempic and Wegovy have slimmed down Hollywood stars and millions of non-celebrities worldwide — all while adding great heft to Denmark's economy.
New Novo Nordisk quality control laboratory in Hillerød
Hillerød, Denmark, 2 December 2024 – Novo Nordisk today announced plans to invest 2.9 billion Danish kroner to establish a cutting-edge quality control laboratory. The new facility, covering 53,000 square meters, will be the company’s largest …
Novo Nordisk Hillerød
Join us at Site Hillerød! At Novo Nordisk Site Hillerød, we are around 4,000 employees developing, producing, and filling injection pens to help patients around the world living with serious chronic diseases, such as diabetes and obesity.